Chemical companies in the US and Europe began exiting the pharmaceutical industry in the mid-1990s, when the British firm ICI ...

TOKYO -- Japan's Mitsubishi Chemical Group announced on Friday the agreed sale of its pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, to U.S. investment fund Bain Capital for approximately ...

Tokyo, Feb. 7 (Jiji Press)--Mitsubishi Chemical Group Corp. said Friday that it will sell subsidiary Mitsubishi Tanabe Pharma Corp. to U.S. investment firm Bain Capital LP. for about 510 billion yen.

TOKYO : Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion ...

TOKYO : Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 ...

The U.S. investment company said Friday that it will buy Mitsubishi Tanabe Pharma for about 510 billion yen, equivalent to $3.37 billion.

BEND, Ore., February 03, 2025--(BUSINESS WIRE)--Mitsubishi Gas Chemical Company, Inc. (MGC), a Japanese methanol manufacturer and supplier for chemical and energy sectors including Methanol-to ...

is the pharmaceutical division of Mitsubishi Chemical Group. Under deal terms announced Friday, this pharma unit, which traces its origins to a Japanese business started in 1638, will split off ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about ¥510 ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about 510 billion ...

TOKYO/HONG KONG, Jan 21 (Reuters) - Japan's Mitsubishi Chemical Group (4188.T), opens new tab has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary ...

TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma ...